B Proteomics ApS: Financial statements 2025
CVR: 44269422
B Proteomics ApS (CVR 44269422) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity amounted to DKK 258,710. The solvency ratio was 55.2%. The company had 2 employees in the financial year.
- Gross Profit
- 747,048 kr.
- Profit/Loss
- 212,153 kr.
- Equity
- 258,710 kr.
- Total Assets
- 468,449 kr.
- Employees
- 2
Find more companies like B Proteomics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
B Proteomics ApS has published its interim report for the period August 30, 2023 – December 31, 2024.
As of February 1, 2025, Jakob Bunkenborg is registered as adm. dir. of B Proteomics ApS.
As of February 1, 2025, Angela Mc Ardle has stepped down as adm. dir. of B Proteomics ApS.
As of January 31, 2025, Jakob Bunkenborg has stepped down as director of B Proteomics ApS.
About B Proteomics ApS
B Proteomics ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Bunkenborg. The company is owned by Bunkarde Holding ApS. In 2025, the company reported a gross profit of DKK 747,048 and a net result of DKK 212,153. Equity amounted to DKK 258,710.
